miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway
2014 · Molecular Cancer · 84 citations
https://doi.org/10.1186/1476-4598-13-234
J
Jun Xiao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
164
Papers
1.6K
Citations
23
h-index
38
i10-index
Jun Xiao is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Renal cell carcinoma treatment & Renal and related cancers & Ferroptosis and cancer prognosis. The author has an h-index of 23, co-authored 140 publications.
ORCID: 0000-0001-9012-1110Papers by this author
worksThe effect-site concentration of remifentanil blunting endotracheal intubation responses during anesthesia induction with etomidate: a dose-finding study
2023 · BMC Anesthesiology · 11 citations
https://doi.org/10.1186/s12871-023-02165-2
Autophagosomes coated in situ with nanodots act as personalized cancer vaccines
2025 · Nature Nanotechnology · 11 citations
https://doi.org/10.1038/s41565-024-01826-8
Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
2021 · Cancer Cell International · 9 citations
https://doi.org/10.1186/s12935-021-02039-y
Eltrombopag directly activates BAK and induces apoptosis
2023 · Cell Death and Disease · 8 citations
https://doi.org/10.1038/s41419-023-05918-6
Machine learning based androgen receptor regulatory gene-related random forest survival model for precise treatment decision in prostate cancer
2024 · Heliyon · 5 citations
https://doi.org/10.1016/j.heliyon.2024.e37256
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat